Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Debio 1562M |
| Trade Name | |
| Synonyms | Debio-1562M|Debio1562M |
| Drug Descriptions |
Debio 1562M is an antibody-drug conjugate (ADC) targeting CD37, which potentially decreases growth of CD37-expressing tumor cells (Cancer Res (2025) 85 (8_Supplement_1): 1160). |
| DrugClasses | CD37 Antibody 9 |
| CAS Registry Number | NA |
| NCIT ID | C219044 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Debio 1562M | Debio 1562M | 0 | 1 |